Centessa Pharmaceuticals plc Quarterly Weighted Average Number of Shares Outstanding, Basic from Q1 2021 to Q2 2024

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
Centessa Pharmaceuticals plc quarterly/annual Weighted Average Number of Shares Outstanding, Basic history and growth rate from Q1 2021 to Q2 2024.
  • Centessa Pharmaceuticals plc Weighted Average Number of Shares Outstanding, Basic for the quarter ending June 30, 2024 was 109M shares, a 15.1% increase year-over-year.
  • Centessa Pharmaceuticals plc annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 96.2M shares, a 2.97% increase from 2022.
  • Centessa Pharmaceuticals plc annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 93.4M shares, a 24.3% increase from 2021.
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 109M +14.3M +15.1% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-13
Q1 2024 99.9M +4.95M +5.21% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-13
Q4 2023 96.2M +2.78M +2.97% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-28
Q3 2023 96.6M +2.32M +2.46% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-13
Q2 2023 95.2M +1.05M +1.12% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-13
Q1 2023 94.9M +4.43M +4.9% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-13
Q4 2022 93.4M +18.2M +24.3% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-28
Q3 2022 94.3M +4.43M +4.93% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-13
Q2 2022 94.1M +30.6M +48.2% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-14
Q1 2022 90.5M +42.5M +88.4% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-12
Q4 2021 75.2M Oct 1, 2021 Dec 31, 2021 10-K 2023-03-30
Q3 2021 89.9M Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
Q2 2021 63.5M Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-10
Q1 2021 48.1M Jan 30, 2021 Mar 31, 2021 10-Q 2022-05-16
* An asterisk sign (*) next to the value indicates that the value is likely invalid.